MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/900/0.01/20.06.25 Stock

Warrant

DE000ME5GL55

Real-time Bid/Ask 05:23:12 2024-05-23 am EDT
0.125 EUR / 0.145 EUR +5.47% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/900/0.01/20.06.25
Current month-6.57%
1 month-8.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.128 -3.03%
24-05-21 0.132 -1.49%
24-05-20 0.134 -2.19%
24-05-17 0.137 +1.48%
24-05-16 0.135 +7.14%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 12:58 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN ME5GL5
ISINDE000ME5GL55
Date issued 2023-12-15
Strike 900 $
Maturity 2025-06-20 (394 Days)
Parity 100 : 1
Emission price 0.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.103
Delta0.16x
Omega 5.540
Premium76.59x
Gearing35.37x
Moneyness 0.5755
Difference Strike 382.1 $
Difference Strike %+42.45%
Spread 0.02
Spread %13.79%
Theoretical value 0.1350
Implied Volatility 39.49 %
Total Loss Probability 92.19 %
Intrinsic value 0.000000
Present value 0.1350
Break even 914.64 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
517.9 USD
Average target price
563.8 USD
Spread / Average Target
+8.85%
Consensus